Abstract
The sensitivity of Plasmodium falciparum strains to chloroquine was tested in one locality in the north-east of the United Republic of Tanzania, where a chloroquine-medicated salt project has been implemented for chemosuppression for many years, and where large amounts of the drug have been available during the last decade for the treatment of malaria infections.
Single doses of chloroquine (5 or 10 mg of base/kg of body weight) failed to clear P. falciparum trophozoites in asymptomatic parasite carriers selected from the school population. In comparison, clearance had been obtained easily ten years previously with 5 mg of base/kg of body weight in several localities in the area.
A total dose of 25 mg of base/kg of body weight given over a 3-day period succeeded in clearing asexual parasites from the peripheral blood by day 3 in all instances. Asexual parasites were not found again during the nine days following administration of the drug.
All the schoolchildren who had received 5 or 10 mg of base/kg of body weight at the beginning of the trial were treated with a further 20 mg of base/kg of body weight at the end of the 7-day observation period. Asexual parasites reappeared in the blood of some of these children 7-10 days after the second administration of the drug.
Using the in vitro microtechnique, incomplete schizont inhibition was observed in 3 out of 21 cases at a chloroquine concentration of 1.14 μmol/litre of blood, which is the discriminating dosage for resistance at RI level.
No cases of retinopathy related to the prolonged use of chloroquine were detected among the 221 residents who had spent more than 16 consecutive years in the locality.
Full text
PDF










Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aronsson B., Bengtsson E., Björkman A., Pehrson P. O., Rombo L., Wahlgren M. Chloroquine-resistant falciparum malaria in Madagascar and Kenya. Ann Trop Med Parasitol. 1981 Aug;75(4):367–373. doi: 10.1080/00034983.1981.11687454. [DOI] [PubMed] [Google Scholar]
- Beale G. H. The genetics of drug resistance in malaria parasites. Bull World Health Organ. 1980;58(5):799–804. [PMC free article] [PubMed] [Google Scholar]
- Bentsi-Enchill K. O. Pigmentary skin changes associated with ocular chloroquine toxicity in Ghana. Trop Geogr Med. 1980 Sep;32(3):216–220. [PubMed] [Google Scholar]
- Bruce-Chwatt L. J. Resistance of P. falciparum to chloroquine in Africa: true or false? Trans R Soc Trop Med Hyg. 1970;64(5):776–784. doi: 10.1016/0035-9203(70)90022-2. [DOI] [PubMed] [Google Scholar]
- Campbell C. C., Chin W., Collins W. E., Teutsch S. M., Moss D. M. Chloroquine-resistant Plasmodium falciparum from East Africa: cultivation and drug sensitivity of the Tanzanian I/CDC strain from an American tourist. Lancet. 1979 Dec 1;2(8153):1151–1154. doi: 10.1016/s0140-6736(79)92383-3. [DOI] [PubMed] [Google Scholar]
- Clyde D. F. Suppression of malaria in Tanzania with the use of medicated salt. Bull World Health Organ. 1966;35(6):962–968. [PMC free article] [PubMed] [Google Scholar]
- Dennis D. T., Doberstyn E. B., Sissay A., Tesfai G. K. Chloroquine tolerance of Ethiopian strains of P. falciparum. Trans R Soc Trop Med Hyg. 1974;68(3):241–245. doi: 10.1016/0035-9203(74)90121-7. [DOI] [PubMed] [Google Scholar]
- Jeffrey G. M., Gibson F. D. Studies on chloroquine-resistance of Plasmodium falciparum in Upper Volta and Liberia, West Africa. Bull World Health Organ. 1966;35(3):441–449. [PMC free article] [PubMed] [Google Scholar]
- Khan A. A., Maguire M. J. Relative chloroquine resistance of P falciparum in Zambia. Br Med J. 1978 Jun 24;1(6128):1669–1670. doi: 10.1136/bmj.1.6128.1669. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lelijveld J., Mzoo F. The effect of small single doses of cloroquine on Plasmodium faiparum infections in north-eastern Tanzania. Bull World Health Organ. 1970;42(3):471–477. [PMC free article] [PubMed] [Google Scholar]
- Mahoney J. L. Chloroquine resistant malaria in Africa. J Trop Med Hyg. 1980 Oct;83(5):207–209. [PubMed] [Google Scholar]
- Olsen V. V., Fogh S. Klorokinresistent Plasmodium falciparum malaria fra Tanzania følsomhedsbestemt in vivo. Ugeskr Laeger. 1981 Apr 13;143(16):1021–1022. [PubMed] [Google Scholar]
- Omer A. H. Response of Plasmodium falciparum in Sudan to oral chloroquine. Am J Trop Med Hyg. 1978 Sep;27(5):853–857. doi: 10.4269/ajtmh.1978.27.853. [DOI] [PubMed] [Google Scholar]
- Rieckmann K. H., Campbell G. H., Sax L. J., Mrema J. E. Drug sensitivity of plasmodium falciparum. An in-vitro microtechnique. Lancet. 1978 Jan 7;1(8054):22–23. doi: 10.1016/s0140-6736(78)90365-3. [DOI] [PubMed] [Google Scholar]
- Stilma J. S. Chloroquine retinopathy in a rural hospital in Ghana. Trop Geogr Med. 1980 Sep;32(3):221–223. [PubMed] [Google Scholar]
- Vedy J., Graveline J., Carrica J., Rivaud C., Chanut G. La rétinopathie par les amino-4-quinoléines dans la prophylaxie du paludisme. Bull Soc Pathol Exot Filiales. 1979 Jul-Aug;72(4):353–357. [PubMed] [Google Scholar]
- Wernsdorfer W. H. Field evaluation of drug resistance in malaria. In vitro micro-test. Acta Trop. 1980 Sep;37(3):222–227. [PubMed] [Google Scholar]
